HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Study to examine vitamin D, omega-3 supplements

This article was originally published in The Tan Sheet

Executive Summary

The Vitamin D and Omega-3 Trial - VITAL - will measure the supplements' preventive effects on cancer, heart disease and stroke in 20,000 participants, making it the largest randomized trial for vitamin D and omega-3 fatty acids. Brigham and Women's Hospital, an affiliate of Harvard Medical School, seeks to enroll women older than 65 and men older than 60 in the five-year study, which will include examinations of how the supplements affect cognitive function, vision disorders and diabetes, the hospital said. BWH Chief of Preventive Medicine JoAnn Manson said June 23 that "these low-cost supplements have the potential of tremendously reducing the burden of chronic disease." Previous economic analysis found omega-3 and vitamin D plus calcium supplementation could save billions in hospitalization costs (1"The Tan Sheet" Sept. 29, 2008, In Brief)

You may also be interested in...

Vitamin D, Omega-3 No Help For Diabetics Against CKD, VITAL Data Show

In latest study casting doubt on the nutrients' effect on chronic illness, researchers find vitamin D and fish oil ineffective in staving off type 2 diabetics' kidney failure. Editorial also published in JAMA says further research is needed to analyze the nutrients’ possible benefits to diabetics with chronic kidney disease.

Men's Vitamin C And D Use Helps Drive Overall VMS Use In Latest CRN Survey

Trade group's annual survey shows 77% of US consumers use supplements. It found 12% more men than four years ago report taking vitamin C or D within the past 12 months.

Low Doses Caused Failures In Omega-3 Heart Health Studies, Says Dyerberg

In Scientific American opinion piece, omega-3 heart benefit research pioneer Jorn Dyerberg says low doses of omega-3s is the reason many studies evaluating their effectiveness have not found a cause-affect link between their daily use and cardiovascular benefits.

Related Content





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts